India Can Heal the World. But Can It Heal Itself?

India has become a global healthcare powerhouse but millions still struggle with access, affordability, and uneven care at home.

Healthcare is a critical driver of any economy. A healthy population improves productivity, supports economic growth, and enhances overall quality of life.

In India, the healthcare sector is evolving along two parallel tracks. On one hand, the country is strengthening its position as the “pharmacy of the world” and emerging as a global hub for medical tourism. On the other hand, system-level data reveals persistent structural gaps – low public spending, uneven infrastructure, and a rising burden of chronic diseases.

India is increasingly positioning itself as a global destination for medical tourism.

According to the NITI Aayog, India ranked 10th out of 46 countries in the Medical Tourism Index for 2020–21.

Several factors are driving this growth. The cost of high-quality medical services in India is significantly lower compared to developed countries, making it an attractive option for international patients.

Many hospitals are equipped with advanced diagnostic and treatment technologies, and India has a large pool of well-trained, English-speaking medical professionals. Additionally, several hospitals are accredited by global bodies such as JCI, ensuring international standards of patient safety and care quality.

Beyond modern medicine, India offers traditional healthcare systems such as Ayurveda, yoga, and naturopathy, creating a unique “treatment plus wellness” proposition.

The country primarily targets patients from Africa, the Middle East, and SAARC nations. Alongside this, the government is working to build a digital health ecosystem to further support medical value travel. Together, these factors indicate that India is gradually shifting toward exporting healthcare services as a part of its broader economic strategy.

However, this outward expansion contrasts sharply with domestic realities. India continues to have low hospital bed density relative to global standards.

Healthcare infrastructure is heavily concentrated in urban areas, where most advanced hospitals largely in the private sector are located.

In contrast, rural areas depend on sub-centres, Primary Health Centres (PHCs), and Community Health Centres (CHCs), which often lack adequate resources.

There is also a significant shortage of specialists at CHCs, including surgeons, gynaecologists, and paediatricians.

This highlights that the challenge is not just about the number of doctors, but also about the availability of specialized care. The urban–rural divide remains one of the biggest structural challenges in India’s healthcare system. At the same time, there is a clear imbalance between public and private healthcare, with the private sector dominating secondary and tertiary care.

Public health spending in India remains low. Government expenditure on healthcare is around 2% of GDP, compared to experts recommended value of 5–6%.

This limited spending contributes to gaps in infrastructure, workforce, and service delivery. While there has been growth in medical colleges and government hospitals, it is still not sufficient to meet the needs of a large and growing population.

Demographic trends further add to the pressure on the system. India’s senior citizen population is projected to reach around 230 million by 2036, accounting for nearly 15% of the total population.

This shift will significantly increase demand for long-term and chronic care services.

Although key health indicators such as Infant Mortality Rate (IMR) and Maternal Mortality Ratio (MMR) have improved over time, progress remains uneven across states.

Another major concern is the high level of Out-of-Pocket Expenditure (OOPE). A large share of healthcare spending in India is borne directly by households, making access to care highly dependent on income levels. This creates a substantial financial burden and increases the risk of households falling into poverty due to medical expenses.

Alongside healthcare services, India’s pharmaceutical industry plays a central role in its global positioning.

According to the Department of Pharmaceuticals Annual Report, India is the third-largest pharmaceutical producer by volume and the 11th largest by value.

The country supplies around 20% of global generic drugs and has the highest number of USFDA-approved pharmaceutical plants outside the United States. India also has approximately 500 active pharmaceutical ingredient (API) manufacturers, contributing about 8% to the global API market.